Pathology In Motion: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Pathology In Motion
Largest movements
- Receivables within one year -€12,971
down €12,971 (-20.0%), from €64,969 to €51,998
of which Trade receivables: -€13,655
- Cash -€11,401
down €11,401 (-57.3%), from €19,894 to €8,493
mainly Trade debts (-€26,075) and Tax, wage and social debts (-€327)
- Trade debts -€26,075
down €26,075 (-32.6%), from €79,915 to €53,840
- Reserves +€2,068
up €2,068 (+45.1%), from €4,584 to €6,651
- Gross operating margin +€1,752
up €1,752 (+79.5%), from €2,202 to €3,954
- Taxes +€803
up €803 (+246%), from €327 to €1,130
- Depreciation -€573
no longer reported in 2025 (was €573)
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €84,863 | €60,491 | -€24,372 | -28.7% |
| Current assets | 29/58 | €84,863 | €60,491 | -€24,372 | -28.7% |
| Amounts receivable within one year | 40/41 | €64,969 | €51,998 | -€12,971 | -20.0% |
| Trade receivables | 40 | €52,912 | €39,257 | -€13,655 | -25.8% |
| Other amounts receivable | 41 | €12,057 | €12,741 | +€684 | +5.7% |
| Cash at bank and in hand | 54/58 | €19,894 | €8,493 | -€11,401 | -57.3% |
| Total equity and liabilities | 10/49 | €84,863 | €60,491 | -€24,372 | -28.7% |
| Equity | 10/15 | €4,584 | €6,651 | +€2,068 | +45.1% |
| Reserves | 13 | €4,584 | €6,651 | +€2,068 | +45.1% |
| Distributable reserves | 133 | €4,584 | €6,651 | +€2,068 | +45.1% |
| Amounts payable | 17/49 | €80,279 | €53,840 | -€26,439 | -32.9% |
| Amounts payable within one year | 42/48 | €80,279 | €53,840 | -€26,439 | -32.9% |
| Trade debts | 44 | €79,915 | €53,840 | -€26,075 | -32.6% |
| Suppliers | 440/4 | €79,915 | €53,840 | -€26,075 | -32.6% |
| Taxes, remuneration and social security | 45 | €327 | - | -€327 | |
| Taxes | 450/3 | €327 | - | -€327 | |
| Other amounts payable | 47/48 | €38 | - | -€38 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €573 | - | -€573 | |
| Other operating charges | 640/8 | €649 | €662 | +€12 | +1.9% |
| Gross operating margin | 9900 | €2,202 | €3,954 | +€1,752 | +79.5% |
| Operating profit (loss) | 9901 | €980 | €3,292 | +€2,312 | +236% |
| Financial charges | 65/66B | €60 | €94 | +€34 | +56.4% |
| Recurring financial charges | 65 | €60 | €94 | +€34 | +56.4% |
| Profit (loss) for the period before taxes | 9903 | €920 | €3,198 | +€2,278 | +248% |
| Income taxes | 67/77 | €327 | €1,130 | +€803 | +246% |
| Profit (loss) for the period | 9904 | €593 | €2,068 | +€1,475 | +249% |
| Profit (loss) for the period to be appropriated | 9905 | €593 | €2,068 | +€1,475 | +249% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 30 October 2026 via checked.be.